Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber

Katarzyna Szot-Karpińska, Piotr Golec, Adam Leśniewski, Barbara Pałys, Frank Marken, Joanna Niedziółka-Jönsson, Grzegorz Wȩgrzyn, Marcin Łoś

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

With the advent of nanotechnology, carbon nanomaterials such as carbon nanofibers (CNF) have aroused substantial interest in various research fields, including energy storage and sensing. Further improvement of their properties might be achieved via the application of viral particles such as bacteriophages. In this report, we present a filamentous M13 bacteriophage with a point mutation in gene VII (pVII-mutant-M13) that selectively binds to the carbon nanofibers to form 3D structures. The phage-display technique was utilized for the selection of the pVII-mutant-M13 phage from the phage display peptide library. The properties of this phage make it a prospective candidate for a scaffold material for CNFs. The results for binding of CNF by mutant phage were compared with those for maternal bacteriophage (pVII-M13). The efficiency of binding between pVII-mutant-M13 and CNF is about 2 orders of magnitude higher compared to that of the pVII-M13. Binding affinity between pVII-mutant-M13 and CNF was also characterized using atomic force microscopy, scanning electron microscopy, and transmission electron microscopy, which confirmed the specificity of the interaction of the phage pVII-mutant-M13 and the CNF; the binding occurs via the phage's ending, where the mutated pVII protein is located. No similar behavior has been observed for other carbon nanomaterials such as graphite, reduced graphene oxide, single-walled carbon nanotubes, and multiwalled carbon nanotubes. Infrared spectra confirmed differences in the interaction with CNF between the pVII-mutant-M13 and the pVII-M13. Basing on conducted research, we hypothesize that the interactions are noncovalent in nature, with π-π interactions playing the dominant role. Herein, the new bioconjugate material is introduced.

Original languageEnglish
Pages (from-to)2900-2910
Number of pages11
JournalBioconjugate Chemistry
Volume27
Issue number12
Early online date16 Nov 2016
DOIs
Publication statusPublished - 21 Dec 2016

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this

Szot-Karpińska, K., Golec, P., Leśniewski, A., Pałys, B., Marken, F., Niedziółka-Jönsson, J., ... Łoś, M. (2016). Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber. Bioconjugate Chemistry, 27(12), 2900-2910. https://doi.org/10.1021/acs.bioconjchem.6b00555

Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber. / Szot-Karpińska, Katarzyna; Golec, Piotr; Leśniewski, Adam; Pałys, Barbara; Marken, Frank; Niedziółka-Jönsson, Joanna; Wȩgrzyn, Grzegorz; Łoś, Marcin.

In: Bioconjugate Chemistry, Vol. 27, No. 12, 21.12.2016, p. 2900-2910.

Research output: Contribution to journalArticle

Szot-Karpińska, K, Golec, P, Leśniewski, A, Pałys, B, Marken, F, Niedziółka-Jönsson, J, Wȩgrzyn, G & Łoś, M 2016, 'Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber', Bioconjugate Chemistry, vol. 27, no. 12, pp. 2900-2910. https://doi.org/10.1021/acs.bioconjchem.6b00555
Szot-Karpińska K, Golec P, Leśniewski A, Pałys B, Marken F, Niedziółka-Jönsson J et al. Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber. Bioconjugate Chemistry. 2016 Dec 21;27(12):2900-2910. https://doi.org/10.1021/acs.bioconjchem.6b00555
Szot-Karpińska, Katarzyna ; Golec, Piotr ; Leśniewski, Adam ; Pałys, Barbara ; Marken, Frank ; Niedziółka-Jönsson, Joanna ; Wȩgrzyn, Grzegorz ; Łoś, Marcin. / Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber. In: Bioconjugate Chemistry. 2016 ; Vol. 27, No. 12. pp. 2900-2910.
@article{1be8e5a316c441218c04a22aa580f3c1,
title = "Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber",
abstract = "With the advent of nanotechnology, carbon nanomaterials such as carbon nanofibers (CNF) have aroused substantial interest in various research fields, including energy storage and sensing. Further improvement of their properties might be achieved via the application of viral particles such as bacteriophages. In this report, we present a filamentous M13 bacteriophage with a point mutation in gene VII (pVII-mutant-M13) that selectively binds to the carbon nanofibers to form 3D structures. The phage-display technique was utilized for the selection of the pVII-mutant-M13 phage from the phage display peptide library. The properties of this phage make it a prospective candidate for a scaffold material for CNFs. The results for binding of CNF by mutant phage were compared with those for maternal bacteriophage (pVII-M13). The efficiency of binding between pVII-mutant-M13 and CNF is about 2 orders of magnitude higher compared to that of the pVII-M13. Binding affinity between pVII-mutant-M13 and CNF was also characterized using atomic force microscopy, scanning electron microscopy, and transmission electron microscopy, which confirmed the specificity of the interaction of the phage pVII-mutant-M13 and the CNF; the binding occurs via the phage's ending, where the mutated pVII protein is located. No similar behavior has been observed for other carbon nanomaterials such as graphite, reduced graphene oxide, single-walled carbon nanotubes, and multiwalled carbon nanotubes. Infrared spectra confirmed differences in the interaction with CNF between the pVII-mutant-M13 and the pVII-M13. Basing on conducted research, we hypothesize that the interactions are noncovalent in nature, with π-π interactions playing the dominant role. Herein, the new bioconjugate material is introduced.",
author = "Katarzyna Szot-Karpińska and Piotr Golec and Adam Leśniewski and Barbara Pałys and Frank Marken and Joanna Niedzi{\'o}łka-J{\"o}nsson and Grzegorz Wȩgrzyn and Marcin Łoś",
year = "2016",
month = "12",
day = "21",
doi = "10.1021/acs.bioconjchem.6b00555",
language = "English",
volume = "27",
pages = "2900--2910",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Modified Filamentous Bacteriophage as a Scaffold for Carbon Nanofiber

AU - Szot-Karpińska, Katarzyna

AU - Golec, Piotr

AU - Leśniewski, Adam

AU - Pałys, Barbara

AU - Marken, Frank

AU - Niedziółka-Jönsson, Joanna

AU - Wȩgrzyn, Grzegorz

AU - Łoś, Marcin

PY - 2016/12/21

Y1 - 2016/12/21

N2 - With the advent of nanotechnology, carbon nanomaterials such as carbon nanofibers (CNF) have aroused substantial interest in various research fields, including energy storage and sensing. Further improvement of their properties might be achieved via the application of viral particles such as bacteriophages. In this report, we present a filamentous M13 bacteriophage with a point mutation in gene VII (pVII-mutant-M13) that selectively binds to the carbon nanofibers to form 3D structures. The phage-display technique was utilized for the selection of the pVII-mutant-M13 phage from the phage display peptide library. The properties of this phage make it a prospective candidate for a scaffold material for CNFs. The results for binding of CNF by mutant phage were compared with those for maternal bacteriophage (pVII-M13). The efficiency of binding between pVII-mutant-M13 and CNF is about 2 orders of magnitude higher compared to that of the pVII-M13. Binding affinity between pVII-mutant-M13 and CNF was also characterized using atomic force microscopy, scanning electron microscopy, and transmission electron microscopy, which confirmed the specificity of the interaction of the phage pVII-mutant-M13 and the CNF; the binding occurs via the phage's ending, where the mutated pVII protein is located. No similar behavior has been observed for other carbon nanomaterials such as graphite, reduced graphene oxide, single-walled carbon nanotubes, and multiwalled carbon nanotubes. Infrared spectra confirmed differences in the interaction with CNF between the pVII-mutant-M13 and the pVII-M13. Basing on conducted research, we hypothesize that the interactions are noncovalent in nature, with π-π interactions playing the dominant role. Herein, the new bioconjugate material is introduced.

AB - With the advent of nanotechnology, carbon nanomaterials such as carbon nanofibers (CNF) have aroused substantial interest in various research fields, including energy storage and sensing. Further improvement of their properties might be achieved via the application of viral particles such as bacteriophages. In this report, we present a filamentous M13 bacteriophage with a point mutation in gene VII (pVII-mutant-M13) that selectively binds to the carbon nanofibers to form 3D structures. The phage-display technique was utilized for the selection of the pVII-mutant-M13 phage from the phage display peptide library. The properties of this phage make it a prospective candidate for a scaffold material for CNFs. The results for binding of CNF by mutant phage were compared with those for maternal bacteriophage (pVII-M13). The efficiency of binding between pVII-mutant-M13 and CNF is about 2 orders of magnitude higher compared to that of the pVII-M13. Binding affinity between pVII-mutant-M13 and CNF was also characterized using atomic force microscopy, scanning electron microscopy, and transmission electron microscopy, which confirmed the specificity of the interaction of the phage pVII-mutant-M13 and the CNF; the binding occurs via the phage's ending, where the mutated pVII protein is located. No similar behavior has been observed for other carbon nanomaterials such as graphite, reduced graphene oxide, single-walled carbon nanotubes, and multiwalled carbon nanotubes. Infrared spectra confirmed differences in the interaction with CNF between the pVII-mutant-M13 and the pVII-M13. Basing on conducted research, we hypothesize that the interactions are noncovalent in nature, with π-π interactions playing the dominant role. Herein, the new bioconjugate material is introduced.

UR - http://www.scopus.com/inward/record.url?scp=85006839780&partnerID=8YFLogxK

U2 - 10.1021/acs.bioconjchem.6b00555

DO - 10.1021/acs.bioconjchem.6b00555

M3 - Article

VL - 27

SP - 2900

EP - 2910

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 12

ER -